Sales decline 7.30% to Rs 426.70 crore
Net profit of Natco Pharma rose 27.49% to Rs 84.40 crore in the quarter ended September 2017 as against Rs 66.20 crore during the previous quarter ended September 2016. Sales declined 7.30% to Rs 426.70 crore in the quarter ended September 2017 as against Rs 460.30 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales426.70460.30 -7 OPM %28.5722.77 -PBDT123.20103.80 19 PBT107.2089.70 20 NP84.4066.20 27Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content